Onco-Innovations Limited

C$0.20As of Sun 8 Nov 2026, 12:00 UTC
NEO:ONCOHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (592.62%)
Biotechnology
Beta (5Y) 2.91
PE TTM —
TSR TTM (87.50%)
Mkt cap C$13.84M
ROIC (257.94%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.203
1.53%
(84.81%)
Buy 1|2|3|8|1
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
5.26%
21.12%
18.03%
24.84%
Revenue$M
1.028
1.000
1.010
1.037
2.53%
1.55%
2.30%
0.43%
Peers (US$9.800M)
Cap (US$)
PE
9.614M
—
Capital
TTM
5Y
10Y
Leveragex
1.564
0.145
0.121
EBIT/Intx
1.186
0.180
0.138
Own earn%
(45.59)
(280.91)
(225.78)
Sh yield%
16.04
45.34
46.99
Owners
Insiders/Inst%
7.00
75.85
Short interest%
4.34
SBC / revenue%
1.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
5–11
$1 testx
−0.3
Incr. ROIC%
14